Extended Data Fig. 6: ROC curves of the different models and of dd-cfDNA as a continuous biomarker or with specific thresholds (0.5 or 1%) in the derivation and validation cohorts.
From: Cell-free DNA for the detection of kidney allograft rejection

Panel A shows the receiver-operating (ROC) curve of different models (model including or without dd-cfDNA), and of dd-cfDNA alone, with or without thresholds. Panel B depicts the ROC curves in the validation cohorts.